Related Experiment Video
Updated: Jun 24, 2026

06:17
Depletion of Specific Cell Populations by Complement Depletion
Published on: February 5, 2010
Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.
Gina LaCorcia1, Mark Swistak, Carla Lawendowski
1Transplant and Immunology Research, Genzyme Corporation, Framingham, MA 01701, USA.
Transplantation
|April 9, 2009
Summary
Rabbit antithymocyte globulin (ATG) consistently induces regulatory T cells and inhibits T-cell activation and migration. This study confirms Thymoglobulin
Area of Science:
- Immunology
- Transplantation Immunology
- Pharmacology
Background:
- Polyclonal antithymocyte globulins (ATGs) are critical in preventing and treating allograft rejection, primarily through T-cell depletion.
- Non-depleting immunomodulatory mechanisms of ATGs are increasingly recognized as vital for graft survival.
- This study investigated the in vitro immunomodulatory activities of 14 batches of Thymoglobulin (rabbit ATG).
Purpose of the Study:
- To systematically analyze and compare the non-depleting immunomodulatory activities of multiple Thymoglobulin lots.
- To assess the consistency of Thymoglobulin's effects on T-cell function and migration.
- To elucidate the mechanisms underlying Thymoglobulin's role in immunoregulation and allograft survival.
Main Methods:
- Human peripheral blood mononuclear cells were co-incubated with Thymoglobulin to induce regulatory T cells (Tregs).
- Treg-mediated suppression of T-cell activation was evaluated in mixed lymphocyte reactions.
- Flow cytometry assessed Thymoglobulin's inhibition of monoclonal antibody binding to T-cell surface antigens (CD2, CD3, CD11a, CD45).
- A transwell chemotaxis assay evaluated Thymoglobulin's inhibition of SDF-1alpha-driven T-cell migration via CXCR4.
Main Results:
- Consistent non-depleting immunomodulatory activities were observed across all 14 Thymoglobulin lots.
- Thymoglobulin consistently induced functionally immunosuppressive regulatory T cells.
- Inhibition of monoclonal antibody binding to key T-cell surface antigens was demonstrated.
- Thymoglobulin effectively inhibited CXCR4/SDF-1alpha-driven T-cell chemotaxis.
Conclusions:
- Systematic in vitro analysis confirms the batch-to-batch consistency of Thymoglobulin.
- Thymoglobulin exhibits significant non-depleting immunomodulatory effects, including Treg induction and inhibition of T-cell activation and migration.
- These findings provide further insight into Thymoglobulin's mechanisms for promoting durable immunoregulation and allograft survival.
More Related Videos
Related Concept Videos
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cell-mediated Immune Responses
Overview

